Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 12489
  • 12490
  • 12491
  • …
  • ›
  • »

2025-11-04

ABEO reports Q2 2025/26 sales growth of 15.5% and 11.8% in H1 of 2025/26

2025-11-04

HERIGE: CONTINUED CONSOLIDATION OF THE BUSINESS, WITH TURNOVER OF EUR 283.2 MILLION FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025

2025-11-04

Bald Hill Antimony Project Under Option From Globex Indicates Potential for 2.7 M Tonnes at 3% to 4% Sb

2025-11-04

EQS-News: Change in the Management Board of First Sensor AG

2025-11-04

Global Bioenergies: postponement of the takeover offers review hearing to 24 November

2025-11-04

Seres Therapeutics Q3 2025 Earnings Preview

2025-11-04

NNIT A/S: On-track performance with doubled profitability

2025-11-04

WideOpenWest, Inc., to Announce Third Quarter 2025 Financial Results

2025-11-04

Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders

2025-11-04

Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

2025-11-04

Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

2025-11-04

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

  • «
  • ‹
  • …
  • 12489
  • 12490
  • 12491
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 27/Aug/2026 19:09:11
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies